Who
Karen Prange
Director
Company insider
Files Form 4 as: Director, AtriCure; Director, Outset Medical; Director, Embecta; Director, Nevro; Director, ViewRay; Director, Cantel Medical; EVP&CEO Gl.AH.Med.Den.Sur.Grp, Henry Schein; SVP&Pres, Uro & Pelvic Health, Boston Scientific.
In numbers
- Trades disclosed
- 93
- Buys
- 1
- Sells
- 12
- Bought
- $100K
- Sold
- $1.7M
- Companies
- 8
- Companies where not an officer
- 6
- First trade
- 28 Feb 2013
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $138K3,564 at $38.80 | filing |
| 5 Aug 2026filed 7 Aug 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $138K3,564 at $38.80 | filing |
| 4 Jun 2026filed 5 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —10,667 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —10,667 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $86K3,000 at $28.65 | filing |
| 20 May 2026filed 22 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $86K3,000 at $28.65 | filing |
| 18 May 2026filed 20 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,144 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —6,144 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | EMBC EmbectaMedical Devices | SEC FORM 4 Code A | —22,841 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | EMBC EmbectaMedical Devices | SEC FORM 4 Code A | —22,841 at $0.00 | filing |
| 9 Jan 2026filed 12 Jan 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —18,667 at $0.00 | filing |
| 9 Jan 2026filed 12 Jan 2026 | OM Outset MedicalMedical Devices | SEC FORM 4 Code A | —18,667 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —5,401 at $0.00 | filing |
| 3 Apr 2025filed 3 Apr 2025 | Nevro | SEC FORM 4 Code D | —33,948 | filing |
| 5 Mar 2025filed 7 Mar 2025 | ATRC AtriCureMedical Devices | SEC FORM 4 Sold | $233K6,100 at $38.12 | filing |
| 12 Feb 2025filed 14 Feb 2025 | EMBC EmbectaMedical Devices | SEC FORM 4 Code A | —13,839 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | Nevro | SEC FORM 4 Code A | —19,169 at $0.00 | filing |
| 13 May 2024filed 14 May 2024 | ATRC AtriCureMedical Devices | SEC FORM 4 Code A | —7,788 at $0.00 | filing |
| 7 Feb 2024filed 9 Feb 2024 | EMBC EmbectaMedical Devices | SEC FORM 4 Code A | —11,455 at $0.00 | filing |
| 21 Jul 2023filed 21 Jul 2023 | ViewRay | SEC FORM 4 Sold | $1,88037,600 at $0.05 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)ATRC · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Karen Prange; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.